OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Tripathy on Treatment De-Escalation in HER2+ Breast Cancer

October 28th 2020

Debu Tripathy, MD, discusses treatment de-escalation in HER2-positive breast cancer.

Dr. Gradishar on the Expanding Role of Trastuzumab Deruxtecan in HER2+ Breast Cancer

October 28th 2020

William J. Gradishar, MD, discusses the expanding role of fam-trastuzumab deruxtecan-nxki in HER2-positive breast cancer.

Dr. Bahary on the Prognosis of BRAF-Mutant Colorectal Cancer

October 28th 2020

Nathan Bahary, MD, PhD, discusses the prognosis of BRAF-mutant colorectal cancer.

Dr. Kasi on the Role of MRD Testing in CRC

October 28th 2020

Pashtoon M. Kasi, MD, MS, discusses the role of minimal residual disease testing in colorectal cancer.

Dr. Theurillat on Castration and AR Inhibition in Prostate Cancer

October 27th 2020

Jean-Philippe Theurillat, MD, discusses castration and androgen receptor inhibition in prostate cancer.

Dr. Davids on the Future of CAR T-Cell Therapy in CLL

October 27th 2020

Matthew S. Davids, MD, MMSc, discusses the future of CAR T-cell therapy in chronic lymphocytic leukemia.

Dr. Lin on the Role of Genomic Markers in Prostate Cancer

October 27th 2020

Daniel W. Lin, MD, discusses the role of genomic markers in prostate cancer.

Dr. Abdulkadir on the Rationale to Target MYC in Prostate Cancer

October 27th 2020

Sarki A. Abdulkadir, MD, PhD, discusses the rationale to target MYC in prostate cancer.

Dr. Tseng on the Goal of the TARPSWG Analysis in Retroperitoneal Sarcoma

October 27th 2020

William W. Tseng, MD, discusses the goals of the Transatlantic Australasian Retroperitoneal Sarcoma Working Group analysis in retroperitoneal sarcoma.

Dr. Tap on the Evolution of Precision Medicine in Soft Tissue Sarcomas

October 27th 2020

William D. Tap, MD, discusses the evolution of precision medicine in soft tissue sarcomas.

Dr. Bahary on Treatment Strategies for Right- Versus Left-Sided Tumors in CRC

October 27th 2020

Nathan Bahary, MD, PhD, discusses treatment strategies for right- versus left-sided tumors in colorectal cancer.

Dr. Jacobson on the Significance of CD19-Targeted CAR T-Cell Therapy in B-Cell Malignancies

October 27th 2020

Caron Jacobson, MD, discusses the significance of CD19-targeted CAR T-cell therapy in B-cell malignancies.

Dr. Ahn on the Significance of the KEYNOTE-177 Trial in mCRC

October 27th 2020

Daniel H. Ahn, DO, discusses the significance of the phase 3 KEYNOTE-177 trial in patients with microsatellite instability–high metastatic colorectal cancer.

Dr. Galligan on Unmet Needs in High-Risk Multiple Myeloma

October 27th 2020

Derek C. Galligan, MD, discusses unmet needs in high-risk multiple myeloma.

Dr. Isaacs on the Evolving Treatment Landscape in HER2+ Breast Cancer

October 27th 2020

Claudine Isaacs, MD, discusses the rapidly evolving HER2-positive breast cancer armamentarium.

Dr. Boutros on Processes That Predict Lethality in Prostate Cancer

October 26th 2020

Paul C. Boutros, PhD, MBA, discusses processes that predict disease lethality in men with prostate cancer.

Dr. Danilov on the Role of Chemoimmunotherapy in CLL

October 26th 2020

Alexey V. Danilov, MD, PhD, discusses the role of chemoimmunotherapy in chronic lymphocytic leukemia.

Dr. Hill on Next Steps for Research Exploring CAR T-Cell Therapy in MCL

October 26th 2020

Brian T. Hill, MD, PhD, discusses next steps for research examining CAR T-cell therapy in mantle cell lymphoma.

Dr. Atkins on the Impact of Georgetown Lombardi Cancer Center Consortium on Sarcoma Treatment

October 26th 2020

Michael B. Atkins, MD, discusses the impact of the Georgetown Lombardi Cancer Center Consortium on the treatment of patients with sarcoma.

Dr. Atkins on the Importance of the Georgetown Lombardi Cancer Center Consortium

October 26th 2020

Michael B. Atkins, MD, discusses the importance of the Georgetown Lombardi Cancer Center Consortium.